OPDP

Sanofi gets FDA untitled letter over Beyfortus promotional emails

The FDA called out Sanofi's characterization of Beyfortus as an RSV preventative, as opposed to its indication for RSV lower respiratory tract disease.

Zoey Becker Jul 22, 2026 2:42pm

ARS Pharma TV ad for Neffy needled by FDA in untitled letter

Jan 29, 2026 11:44am

FDA chides BeOne, ImmunityBio in separate untitled letters

Jan 15, 2026 11:50am

FDA takes issue with AstraZeneca TV ad for Farxiga

Nov 18, 2025 10:50am

Novartis earns FDA ire for 'misleading' Fabhalta ad imagery

Sep 30, 2025 11:12am

Sprout hit with FDA warning letter over CEO’s Instagram post

Jun 12, 2025 12:00pm